News Archive

Date: 07/19/2012
Researchers at the University of Michigan Comprehensive Cancer Center, led by Max Wicha, MD, have discovered breast cancer cells with the HER2 marker turn on a cellular pathway that makes them resistant to Herceptin over time.
Date: 07/16/2012
U-M earns a spot on national U.S. News Honor Roll for 18th straight year, comes out on top of new state ranking.
Date: 07/16/2012
A new study lead by University of Michigan Comprehensive Cancer Center researchers, led by lead author Bradley Zebrack, Ph.D., MSW, MPH; shows significant proportions of adolescents and young adult cancer patients are not getting their care needs met.
Date: 07/09/2012
UMSkinCheck tracks skin changes, offers skin check reminders.
Date: 06/22/2012
Dr. Lisa Newman named 'Michiganian of the Year'Written by Nicole Fawcett
Date: 06/19/2012
Combining a new targeted therapy with standard chemotherapy may help defeat pancreatic cancer, according to results presented at the American Association for Cancer Research's Pancreatic Cancer: Progress and Challenges conference.
Date: 06/12/2012
Reshma Jagsi, M.D., D.Phil., associate professor at the University of Michigan Medical School, was lead author of the study that found, after taking specialty, productivity and other factors into consideration, gender disparity still exists among doctors.
Date: 06/04/2012
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59% of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
Date: 06/04/2012
Over men 1200 men with metastatic, hormone-sensitive prostate cancer were given intermittent androgen-deprivation (AD) therapy after seven months of androgen deprivation. The results show intermittent hormone therapy offers some quality-of-life benefits, but lower overall survival.
Date: 05/21/2012
Cancer survivors, their families and friends will be playing the hope card on June 3, 2012.